P

Puma Biotechnology

D

PBYI

USD

0.055

(2.2%)

Market Closed

3,567.00

حجم التداول

0.31

الربح لكل سهم

-

العائد الربحي

13.447

P/E

125,314,377.27

حجم السوق

اليوم

2.2000%

1 اسبوع

1.793%

1 شهر

-9.558%

6 اشهر

-40.443%

12 اشهر

-14.548%

بداية السنة

-41.129%

كل الوقت

0%

أصول ذات صلة

Title:
Puma Biotechnology

Sector:

Healthcare

Industry:

Biotechnology

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا